021-51111890
购物车（）
sales@molnova.cn
STO-609 acetate
CAS No. 1173022-21-3
STO-609 acetate ( —— )
产品货号. M17166 CAS No. 1173022-21-3
STO-609 acetate is selective, cell-permeable inhibitor of Ca2+-calmodulin-dependent protein kinase kinase (Ki: 80/15 ng/ml, for CaM-KKα/KKβ); competes for the ATP-binding site.
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥446 | 有现货 |
|
| 5MG | ￥745 | 有现货 |
|
| 10MG | ￥1377 | 有现货 |
|
| 25MG | ￥2187 | 有现货 |
|
| 50MG | ￥3418 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称STO-609 acetate
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述STO-609 acetate is selective, cell-permeable inhibitor of Ca2+-calmodulin-dependent protein kinase kinase (Ki: 80/15 ng/ml, for CaM-KKα/KKβ); competes for the ATP-binding site.
-
产品描述STO-609 acetate is selective, cell-permeable inhibitor of Ca2+-calmodulin-dependent protein kinase kinase (Ki: 80/15 ng/ml, for CaM-KKα/KKβ); competes for the ATP-binding site. It displays > 80-fold selectivity over CaMK1/2/4, PKC, MLCK, PKA and p42 MAPK.
-
同义词——
-
通路Autophagy
-
靶点Autophagy
-
受体CaM-KKα; CaM-KKβ
-
研究领域Neurological Disease
-
适应症——
化学信息
-
CAS Number1173022-21-3
-
分子量374.35
-
分子式C19H10N2O3·C2H4O2
-
纯度98%
-
溶解度——
-
SMILESCC(=O)O.c1ccc2c(c1)nc1n2c(=O)c2cccc3c(ccc1c23)C(=O)O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Tokumitsu H, et al. J Biol Chem. 2002 May 3;277(18):15813-8.
产品手册
关联产品
-
SMER-28
A small-molecule enhancer/inducer of Autophagy; decreases the levels of Aβ peptide (EC50=10 uM) and APP-CTF (EC50 of 20 uM) in a γ-secretase-independent manner in primary neuronal cultures, Atg5, Beclin1 and Ulk1 are shown to be involved in the degradation of Aβ and APP-CTF.
-
CA-5f
CA-5f is a potent late-stage macroautophagy/autophagy inhibitor via inhibiting autophagosome-lysosome fusion.
-
ULK-101
ULK-101 is a potent and selective ULK1 inhibitor ( IC50s: 8.3/30 nM for ULK1/ULK2).
